Cart
sales@molnova.com
Home - Products - Others - Other Targets - Etebenecid

Etebenecid

CAS No. 1213-06-5

Etebenecid( Urelim )

Catalog No. M26681 CAS No. 1213-06-5

Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 28 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Etebenecid
  • Note
    Research use only, not for human use.
  • Brief Description
    Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
  • Description
    Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys. It also inhibits penicillin tubular secretion.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Urelim
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    prostaglandin F2α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1213-06-5
  • Formula Weight
    257.3
  • Molecular Formula
    C11H15NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (971.59 mM)
  • SMILES
    CCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vallera C, et al. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol. Anesthesiol Clin. 2017 Jun;35(2):207-219.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • (Pro30,Tyr32,Leu34)-...

    (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36)

  • [Lys3]–Bombesin

    [Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)

  • Lytic Peptide, Shiva...

    Lytic Peptide, Shiva – 1

Sign In Join Free